Eli Lilly, spurred by AI analysis, starts pivotal study of arthritis med Olumiant in COVID-19
admin 15th June 2020 Uncategorised 0 Eli Lilly, spurred by AI analysis, starts pivotal study of arthritis med Olumiant in COVID-19
aliu
Mon, 06/15/2020 – 10:45
More: Eli Lilly, spurred by AI analysis, starts pivotal study of arthritis med Olumiant in COVID-19
Source: fierce